Shots: The US FDA has granted the FT designation to the Moderna’s mRNA vaccine (mRNA-1273) candidate against COVID-19. FT designation is designed to facilitate the development and expedite the review […]readmore
Tags : Moderna
1.Fitbit Launches Heart Study to Validate its Wearable Technology for Identifying Atrial Fibrillation Published: May 06, 2020 | Tags: Fitbit, Launches, Heart Study, Validate, Wearable Technology, Identifying, Atrial Fibrillation 2. […]readmore
Shots: The company reported in its Q1 results that the US FDA has accepted its NDA of (mRNA-1273) and allow it to initiate P-II study evaluating the therapy in 600 […]readmore
WuXi Biologics and Aravive Collaborate to Develop Novel High-Affinity Bispecific Antibodies for Cancer and Fibrosis Published: Apr 30, 2020 | Tags: WuXi Biologics, Aravive, Collaborate, Develop, Novel, High-Affinity Bispecific Antibodies, Cancer, […]readmore
The recent emergence of the coronavirus SARS-CoV-2 and the COVID-19 pandemic has spurred global healthcare and life sciences companies, as well as government agencies, to partner at unprecedented speed to […]readmore
Our planet is facing a major pandemic outbreak due to COVID-19 and health agencies are taking every measure to stop it The outbreak of the respiratory disease was first detected […]readmore
Shots: :stohththShots: The companies intend to establish manufacturing suites at Lonza’s facilities in the US and Switzerland to manufacture mRNA-1273 at both sites. The collaboration will deploy Lonza’s global expertise […]readmore
Shots: Moderna has submitted the IND to the US FDA to evaluate its mRNA vaccine candidate (mRNA-1273) in a P-II and late-stage studies upon IND acceptance and safety data from […]readmore
1. Sinovac Initiates the P-I Clinical Study for Vaccine Candidate Against COVID-19 Published: Apr 17, 2020 | Tags: Sinovac, Initiates, P-I, Clinical Study, Vaccine Candidate, Against, COVID-19 2. 1Health.io Launches Self-Collection […]readmore
Shots: BARDA will fund ~$483M for the advancement of mRNA-1273 to FDA licensure. The funding will scale-up the manufacturing process and enables a large-scale production in 2020 while Moderna plans […]readmore